- Home
- HOPE vs GENB Comparison
HOPE vs GENB Comparison
Compare HOPE & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HOPE | GENB |
|---|---|---|
| Founded | 1986 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2000 | 2026 |
Fundamental Metrics
Financial Performance| Metric | HOPE | GENB |
|---|---|---|
| Price | $14.45 | $15.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $14.50 | ★ $23.20 |
| AVG Volume (30 Days) | ★ 1.1M | 476.8K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.00 | N/A |
| Revenue Next Year | $19.66 | $16.58 |
| P/E Ratio | $29.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.80 | $11.00 |
| 52 Week High | $14.50 | $18.18 |
Technical Indicators
Market Signals| Indicator | HOPE | GENB |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 59.66 |
| Support Level | $13.09 | $11.82 |
| Resistance Level | $14.48 | $16.75 |
| Average True Range (ATR) | 0.24 | 0.84 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 79.26 | 98.18 |
Price Performance
Historical ComparisonAbout HOPE Hope Bancorp Inc.
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services, and other banking services.
About GENB Generate Biomedicines Inc. Common Stock
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.